GSX1 is a transcription factor that binds specific DNA sequences and plays critical roles in neural development and disease pathology. GSX1 functions as a homeobox gene within the ParaHox cluster 1, exhibiting redundant roles with its homolog Gsx2 in suppressing oligodendrocyte progenitor cell (OPC) specification in the lateral ganglionic eminence during telencephalic development 2. During cerebellar neurogenesis, BMP/SMAD signaling transcriptionally represses Gsx1 in early progenitors, and gradual decline of this repression allows temporal fate transition toward late-born interneuron specification 3. GSX1-expressing neurons in the dorsal brainstem are essential for prepulse inhibition, a sensory gating mechanism; Gsx1 knockout mice and zebrafish with ablated Gsx1 neurons show profound PPI deficits, linking interneuron specification control to sensory information filtering 4. Beyond neurodevelopment, GSX1 has clinical relevance as a biomarker for cervical cancer screening: DNA methylation patterns in the GSX1 locus contribute to the WID-qCIN test, which detects cervical intraepithelial neoplasia grade 3 with 78-100% sensitivity and 90% specificity in HPV-positive women 56. Additionally, GSX1 methylation in the hippocampus correlates with age-related spatial memory decline in rats 7, and a genetic variant near GSX1 associates with reduced pancreatic fat content and lower type 2 diabetes risk 8.